CA
NZ
UK
AU
IND
US
HCM III Acquisition Corp. filed its Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 14, 2026, reporting financial results for the three and six months ended June 30, 2026.
Michael J. Happe, President and CEO of Winnebago Industries Inc., filed a Form 4 on August 14, 2026, disclosing a stock option exercise and a subsequent sale of common shares on August 13, 2026, pursuant to a Rule 10b5-1 trading plan.
A statement of changes in beneficial ownership was filed on August 14, 2026, disclosing that Jesse Weaver, Chief Financial Officer of Holley Inc. (NYSE:HLLY), had 32,457 shares of common stock withheld on August 12, 2026, to cover required tax obligations upon the vesting of …
Bret A. Woodson, SVP-CHRO of Winnebago Industries, Inc. (NYSE:WGO), filed a Form 4 on August 14, 2026, disclosing transactions in common stock dated August 13, 2026, made pursuant to a Rule 10b5-1(c) plan.
A statement of changes in beneficial ownership was filed on August 14, 2026, disclosing that Peter George Charles Andrew Stokes, a director of Navigator Holdings Ltd., sold 5,000 shares of common stock on August 12, 2026.
Matthew Stevenson, President and CEO of Holley Inc., filed a Form 4 on August 14, 2026, reporting an automatic share withholding transaction on August 12, 2026, related to the vesting of restricted stock.
A Form 4 filed with the SEC on August 14, 2026, discloses that Diane Poillon, a director of Burke & Herbert Financial Services Corp. (NASDAQ:BHRB), purchased 1,200 shares of common stock on August 12, 2026.
A Form 4 filed on August 14, 2026 disclosed that Zehava Simon, a director of NICE Ltd. (NASDAQ:NICE), exercised stock options to acquire 554 ordinary shares on August 13, 2026.
Lin Yu-Hsin, Chief Executive Officer and Director of Belite Bio, Inc, filed a Form 4 on August 14, 2026, disclosing the sale of 365 American depositary shares on August 12, 2026, under a pre-established Rule 10b5-1 trading plan.
Hao-Yuan Chuang, Chief Financial Officer and Director of Belite Bio, Inc (NASDAQ:BLTE), filed a Form 4 on August 14, 2026, disclosing the sale of 367 American depositary shares on August 12, 2026, pursuant to a Rule 10b5-1 trading plan.
Please wait processing your request...